Contents
Current Cancer Drug Targets, Volume 11 - Number 1
Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?
, 11(1): 3 - 19H. Rumpold and G. Webersinke
DOI: 10.2174/156800911793743619
Molecular Pathogenesis of Philadelphia Chromosome Negative Chronic Myeloproliferative Neoplasms
, 11(1): 20 - 30R. Jager and R. Kralovics
DOI: 10.2174/156800911793743628
Current Treatment Concepts of CML
, 11(1): 31 - 43A. A. Leitner, A. Hochhaus and M. C. Muller
DOI: 10.2174/156800911793743637
Current Treatment Concepts of Philadelphia-Negative MPN
, 11(1): 44 - 55D. Wolf, J. Rudzki and G. Gastl
DOI: 10.2174/156800911793743592
Immunotherapy for Myeloproliferative Neoplasms (MPN)
, 11(1): 72 - 84Susanne Hofmann, Anna Babiak and Jochen Greiner
DOI: 10.2174/156800911793743682
Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
, 11(1): 85 - 102S. Cecco, E. Muraro, E. Giacomin, D. Martorelli, R. Lazzarini, P. Baldo and R. Dolcetti
DOI: 10.2174/156800911793743664
Chronic Vaccination with a Therapeutic EGF-Based Cancer Vaccine: A Review of Patients Receiving Long Lasting Treatment
, 11(1): 103 - 110G. Gonzalez, T. Crombet and A. Lage
DOI: 10.2174/156800911793743583
High Therapeutic Potential for Systemic Delivery of a Liposomeconjugated Herpes Simplex Virus
, 11(1): 111 - 122T. Shikano, H. Kasuya, T. T. Sahin, N. Nomura, A. Kanzaki, M. Misawa, Y. Nishikawa, T. Shirota, S. Yamada, T. Fujii, H. Sugimoto, N. Kanazumi, S. Nomoto, S. Takeda and A. Nakao
DOI: 10.2174/156800911793743673
Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
, 11(1): 123 - 129D. Santini, G. Schiavon, B. Vincenzi, C. E. Cass, E. Vasile, A. D. Manazza, V. Catalano, G. G. Baldi, R. Lai, S. Rizzo, A. Giacobino, L. Chiusa, M. Caraglia, A. Russo, J. Mackey, A. Falcone and G. Tonini
DOI: 10.2174/156800911793743600
Webmaster Contact: info@benthamscience.net